Here's Why GlycoMimetics Is Soaring 24.3% Higher Today
![Here's Why GlycoMimetics Is Soaring 24.3% Higher Today Here's Why GlycoMimetics Is Soaring 24.3% Higher Today](https://g.foolcdn.com/editorial/images/466395/gettyimages-547234332.jpg)
After unveiling updated results from a trial evaluating GMI-1271 in relapsed or refractory acute myeloid leukemia (AML), GlycoMimetics (NASDAQ: GLYC) shares are surging 24.3% as of noon EST Tuesday.
In June, GlycoMimetics provided results for GMI-1271 at the American Society of Clinical Oncology (ASCO) annual meeting. At the time, results from this phase 1/2 study failed to impress, causing shares to sell-off.
Image source: Getty Images.
Source: Fool.com
Glycomimetics Inc. Aktie
Leichtes Sell-Interesse bei Glycomimetics Inc., mit mehr Sell- als Buy-Einschätzungen.
Für Glycomimetics Inc. ergibt sich ein Potenzial von 6115.47%, selbst wenn das Kursziel von 9 € über dem aktuellen Kurs von 0.14 € liegt.